STAAR Surgical Company | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (40)

Latest Posts

About This Stock More About This Stock
Futures Reverse Overnight Losses As More Curves Invert, Yen Plummets To 7 Year Low
Article By: Tyler Durden
Monday, March 28, 2022 10:32 AM EDT
After initially sliding lower, US equity futures reversed and erased earlier declines, climbing 0.2% along with Nasdaq futures as Stoxx Europe 600 extends gains to 1.1%.
In this article: QQQ, DIA, SPX, MGM, STAA, BYND, QRVO, MLCO, BNO, OIL, UCO, UGA, UNG, USO, GLD, JJC (RETIRED), JJU (RETIRED), SLV, FXE, FXA, FXB, FXF, FXY, UUP
Read
Profits Taken S&P Short Sale
Video By: Robert Desmond
Wednesday, June 20, 2018 7:07 AM EDT
A review of the pre-market activity of the stock market and the currency markets.
In this video: JPM, FXE, QQQ, STAA, COST, DECK, DIA, FXY, GLD, ITA, SPY, UUP, SPX, GOOS
Watch
Premarket Biotech Digest – Teva, MannKind, Quidel, Applied DNA Sciences Reported Earnings
Article By: KKD Healthcare Analytics
Friday, May 12, 2017 5:40 AM EDT
Teva Pharmaceutical Industries announced its first quarter results. Applied DNA Sciences reported its second quarter loss at $3.4 million.
In this article: BSX, MNKD, QDEL, STAA, TEVA, XNCR, CRBP, AIMT, APDN, NSPR
Read
Glaukos IPO Lockup Expiration Warrants Your Immediate Attention
Article By: Don Dion
Friday, December 11, 2015 1:01 PM EDT
December 22, 2015 concludes the 180-day lockup period on Glaukos Corporation. Glaukos priced its IPO at $18 per share, considerably higher than its expected price range of $13 to $15.
In this article: GKOS Also: ABT, STAA, LMNS
Read

Latest Tweets for $STAA

No tweets yet!

PARTNER HEADLINES